"[T]he individual mandate is a strange sort of law, so even if the court has established a precedent here that the Commerce Power doesn't authorize Congress to create commerce, that precedent may not have much if any practical significance for other laws," Magarian wrote in an email.
Where's this leave Roberts?
Possibly with one brilliant piece of judicial strategizing.
"If you're imagining a Chief Justice writing this as a judicial politician trying to satisfy constituencies -- you know, give the conservatives something of a bone, don't strike the thing down, write something narrow -- I think you couldn't be much more crafty than this," said Magarian. "Roberts is kind of being a master politician here."
Republican presidential nominee Mitt Romney stopped short on Thursday of disparaging the Supreme Court, saying that the ruling determined Obamacare didn't violate the U.S. Constitution. Barack Obama played it safe by saying American lives would be more secure because of the high court's decision. Their comments understate that Thursday's Obamacare ruling is likely the most crucial decision by the Supreme Court since Bush v. Gore in 2000, when then-Chief Justice William Rehnquist wrote the majority opinion. It appears that Roberts just had his Bush v. Gore moment. Medicaid HMOs soared after the ruling, largely due to an expected 16 to 20 million new Americans who would be eligible to enroll in the government program in 2014: Amerigroup (AGP) was at $65.47, up $3.07 or 4.9%, Molina (MOH) at $23.16, up $1.84, or 8.6%, and Centene (CNC) at $30.59, up 68 cents or 2.3%. Diversified health care companies fell on the news as the regulatory burdens set by Obamacare -- minimum medical loss ratio, exchanges and rate reviews -- are expected to cause them trouble. Aetna (AET) closed at $39.85, down $1.11, or 2.7%, Cigna (CI) was at $44.18, down $1.22, or 2.7%, and Coventry (CVH) at $32.46, down 77 cents, or 2.3%. -- Written by Joe Deaux in New York. >Contact by Email. Follow @JoeDeauxSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV